T1DM or Autoimmune diabetes

GABA-based therapy for autoimmune diabetes (TIDM):GABA(Gamma amminobutryic acid) increases PD-L1 expression, increases Tregs function, promotes immune tolerance, increases pancreatic β-cell proliferation and regeneration, increases insulin secretion, improves insulin sensitivity, increases energy utilization, and reverses TIDM, via up regulation of its target gene, 14/May/2018, 11.58 pm
GABA-based therapy for autoimmune diabetes (TIDM):GABA(Gamma amminobutryic acid) increases PD-L1 expression, increases Tregs function, promotes immune tolerance, increases pancreatic β-cell proliferation and regeneration, increases insulin secretion, improves insulin sensitivity, increases energy utilization, and reverses TIDM, via up regulation of its target gene, 14/May/2018, 11.58 pm 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say A study from the International Center for T1D, Pediatric Clinical Research Center Romeo ed Enrica Invernizzi, “L. Sacco” Department of Biomedical and Clinical Sciences, University of Milan, Milan…

read more

Amino acid-based therapy for autoimmune diabetes (TIDM): Leucine increases PD-L1 expression, increases Tregs function, promotes immune tolerance, increase insulin secretion, improves insulin sensitivity, increases energy utilization, and reverses TIDM via up regulation of its target gene, 12/February/2018,11.14 pm
Amino acid-based therapy for autoimmune diabetes (TIDM): Leucine increases PD-L1 expression, increases Tregs function, promotes immune tolerance, increase insulin secretion, improves insulin sensitivity, increases energy utilization, and reverses TIDM via up regulation of its target gene, 12/February/2018,11.14 pm 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say A study from the International Center for T1D, Pediatric Clinical Research Center Romeo ed Enrica Invernizzi, “L. Sacco” Department of Biomedical and Clinical Sciences, University of…

read more
Start Typing